Prestige Consumer Healthcare Inc.(PBH)Earnings, Financials & Key Ratios

PBH•NYSE

$55.75

$2.64B mkt cap·13.0× P/E·Price updated May 6, 2026

SectorHealthcare IndustryMedical Distribution Sub-IndustryDrug Wholesalers and Distributors

AboutPrestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.Show more

Revenue$1.14B+1.1%
EBITDA$367M-1.6%
Net Income$215M+2.5%
EPS (Diluted)4.29+2.9%
Gross Margin55.76%+0.5%
EBITDA Margin32.25%-2.7%
Operating Margin29.6%-2.7%
Net Margin18.86%+1.4%
ROE12.3%-8.9%
ROIC9.14%-2.1%
Debt/Equity0.57-17.4%
Interest Coverage7.07+38.7%

Technical→

PBH Key Insights

Prestige Consumer Healthcare Inc. (PBH) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Strong Piotroski F-Score: 8/9
✓FCF machine: 21.4% free cash flow margin
✓Healthy 5Y average net margin of 13.3%

✗Weaknesses

✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

PBH Price & Volume

Prestige Consumer Healthcare Inc. (PBH) stock price & volume — 10-year historical chart

Loading chart...

PBH Growth Metrics

Prestige Consumer Healthcare Inc. (PBH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years4.76%

5 Years3.39%

3 Years1.54%

TTM-1.27%

Profit CAGR

10 Years10.61%

5 Years8.57%

3 Years1.48%

TTM-12.82%

EPS CAGR

10 Years11.15%

5 Years9.06%

3 Years2.02%

TTM-11.48%

Return on Capital

10 Years7.13%

5 Years7.8%

3 Years6.8%

Last Year10.37%

PBH Recent Earnings

Prestige Consumer Healthcare Inc. (PBH) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 8/12 qtrs (67%)●Beat Revenue 9/12 qtrs (75%)

Q1 2026Latest

Feb 5, 2026

EPS

$1.14

Est $1.16

-1.7%

Revenue

$283M

Est $282M

+0.4%

Q4 2025

Nov 6, 2025

EPS

$1.07

Est $0.97

+10.3%

Revenue

$274M

Est $294M

-6.8%

Q3 2025

Aug 7, 2025

EPS

$0.95

Est $1.01

-5.9%

Revenue

$250M

Est $275M

-9.3%

Q2 2025

May 8, 2025

EPS

$1.32

Est $1.30

+1.5%

Revenue

$297M

Est $270M

+9.7%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q1 2026Latest	Feb 5, 2026	$1.14vs $1.16-1.7%	$283Mvs $282M+0.4%
Q4 2025	Nov 6, 2025	$1.07vs $0.97+10.3%	$274Mvs $294M-6.8%
Q3 2025	Aug 7, 2025	$0.95vs $1.01-5.9%	$250Mvs $275M-9.3%
Q2 2025	May 8, 2025	$1.32vs $1.30+1.5%	$297Mvs $270M+9.7%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	FCF Yield	Debt / Equity
SPBSpectrum Brands Holdings, Inc.Direct Competitor	1.92B	82.38	21.34	-5.23%	3.76%	5.52%	8.65%	0.34
CHDChurch & Dwight Co., Inc.Direct Competitor	22.15B	93.53	30.97	1.57%	11.81%	17.45%	4.93%	0.55
ENREnergizer Holdings, Inc.Direct Competitor	1.22B	17.85	5.38	2.28%	6.55%	116.9%	5.16%	20.79
PRGOPerrigo Company plcDirect Competitor	1.6B	11.64	-1.13	-2.75%	-33.51%	-48.56%	9.06%	0.01
COTYCoty Inc.Direct Competitor	2.25B	2.56	-5.82	-3.68%	-9.26%	-14.21%	12.32%	1.07
KVUEKenvue Inc.Direct Competitor	33.28B	17.37	32.17	0.07%	9.55%	13.48%	4.01%	0.90
HLNHaleon plcDirect Competitor	40.84B	9.17	18.74	-3.96%	14.46%	19.9%	6.56%	0.52
HIMSHims & Hers Health, Inc.Product Competitor	6.8B	26.33	51.63	59%	5.47%	23.73%	1.09%	2.07

Compare PBH vs Peers

Prestige Consumer Healthcare Inc. (PBH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs SPB

Most directly comparable listed peer for PBH.

Scale Benchmark

vs AMZN

Larger-name benchmark to compare PBH against a more recognizable public peer.

Peer Set

Compare Top 5

vs SPB, CHD, ENR, PRGO

PBH Income Statement

Prestige Consumer Healthcare Inc. (PBH) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Sales/Revenue	882.06M	1.04B	975.78M	963.01M	943.37M	1.09B	1.13B	1.13B	1.14B	1.1B
Revenue Growth %	9.4%	18.04%	-6.28%	-1.31%	-2.04%	15.21%	3.76%	-0.21%	1.1%	-1.27%
Cost of Goods Sold	381.77M	464.67M	420.2M	410.79M	395.89M	466.17M	502.43M	500.91M	503.3M	481.54M
COGS % of Revenue	43.28%	44.63%	43.06%	42.66%	41.97%	42.89%	44.55%	44.51%	44.24%	-
Gross Profit	500.29M▲ 0%	576.5M▲ 15.2%	555.58M▼ 3.6%	552.22M▼ 0.6%	547.47M▼ 0.9%	620.65M▲ 13.4%	625.29M▲ 0.7%	624.45M▼ 0.1%	634.46M▲ 1.6%	622.3M▲ 0%
Gross Margin %	56.72%	55.37%	56.94%	57.34%	58.03%	57.11%	55.45%	55.49%	55.76%	56.38%
Gross Profit Growth %	7.08%	15.24%	-3.63%	-0.6%	-0.86%	13.37%	0.75%	-0.14%	1.6%	-
Operating Expenses	242.85M	360.64M	259.9M	261.07M	250.07M	290.73M	647.71M	282.02M	297.69M	299.95M
OpEx % of Revenue	27.53%	34.64%	26.63%	27.11%	26.51%	26.75%	57.44%	25.06%	26.16%	-
Selling, General & Admin	217.5M	332.21M	232.85M	236.31M	223.69M	264.8M	252.41M	259.47M	263.93M	263.91M
SG&A % of Revenue	24.66%	31.91%	23.86%	24.54%	23.71%	24.37%	22.38%	23.06%	23.2%	-
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	25.35M	28.43M	-476K	24.76M	26.38M	25.93M	395.29M	22.55M	33.76M	3M
Operating Income	205.61M▲ 0%	215.87M▲ 5.0%	67.5M▼ 68.7%	291.15M▲ 331.3%	297.4M▲ 2.1%	329.92M▲ 10.9%	-22.41M▼ 106.8%	342.43M▲ 1627.7%	336.77M▼ 1.7%	322.35M▲ 0%
Operating Margin %	23.31%	20.73%	6.92%	30.23%	31.53%	30.36%	-1.99%	30.43%	29.6%	29.2%
Operating Income Growth %	-21.01%	4.99%	-68.73%	331.32%	2.15%	10.93%	-106.79%	1627.68%	-1.65%	-
EBITDA	231.41M	249.29M	99.28M	328.94M	327.57M	362.01M	10.21M	373.1M	366.95M	352.52M
EBITDA Margin %	26.23%	23.94%	10.17%	34.16%	34.72%	33.31%	0.91%	33.15%	32.25%	31.94%
EBITDA Growth %	-18.52%	7.73%	-60.17%	231.31%	-0.42%	10.52%	-97.18%	3554.3%	-1.65%	-1.78%
D&A (Non-Cash Add-back)	25.79M	33.43M	31.78M	37.78M	30.16M	32.09M	32.63M	30.68M	30.17M	30.17M
EBIT	204.4M	322.3M	67.03M	287.72M	286.44M	326.75M	-24.75M	343.19M	331.82M	308.35M
Net Interest Income	-93.34M	-105.88M	-105.08M	-96.22M	-82.33M	-64.29M	-69.16M	-67.16M	-47.63M	-41.67M
Interest Income	203K	388K	217K	342K	0	0	0	0	0	0
Interest Expense	93.55M	106.27M	105.3M	96.57M	82.33M	64.29M	69.16M	67.16M	47.63M	41.67M
Other Income/Expense	-94.79M	-108.39M	-105.56M	-100M	-93.29M	-67.46M	-71.5M	-66.4M	-52.59M	-55.66M
Pretax Income	110.85M▲ 0%	107.09M▼ 3.4%	-38.05M▼ 135.5%	191.15M▲ 602.3%	204.11M▲ 6.8%	262.46M▲ 28.6%	-93.92M▼ 135.8%	276.02M▲ 393.9%	284.19M▲ 3.0%	266.68M▲ 0%
Pretax Margin %	12.57%	10.29%	-3.9%	19.85%	21.64%	24.15%	-8.33%	24.53%	24.98%	24.16%
Income Tax	41.45M	-232.48M	-2.25M	48.87M	39.43M	57.08M	-11.61M	66.69M	69.58M	80.18M
Effective Tax Rate %	37.4%	-217.1%	5.93%	25.57%	19.32%	21.75%	12.36%	24.16%	24.49%	30.07%
Net Income	69.39M▲ 0%	339.57M▲ 389.3%	-35.8M▼ 110.5%	142.28M▲ 497.4%	164.68M▲ 15.7%	205.38M▲ 24.7%	-82.31M▼ 140.1%	209.34M▲ 354.3%	214.6M▲ 2.5%	186.5M▲ 0%
Net Margin %	7.87%	32.61%	-3.67%	14.77%	17.46%	18.9%	-7.3%	18.6%	18.86%	16.9%
Net Income Growth %	-30.54%	389.33%	-110.54%	497.43%	15.74%	24.71%	-140.07%	354.34%	2.52%	-12.82%
Net Income (Continuing)	69.39M	339.57M	-35.8M	142.28M	164.68M	205.38M	-82.31M	209.34M	214.6M	186.5M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	1.30▲ 0%	6.34▲ 387.7%	-0.69▼ 110.9%	2.78▲ 502.9%	3.25▲ 16.9%	4.04▲ 24.3%	-1.65▼ 140.8%	4.17▲ 352.7%	4.29▲ 2.9%	3.88▲ 0%
EPS Growth %	-30.85%	387.69%	-110.88%	502.9%	16.91%	24.31%	-140.84%	352.73%	2.88%	-11.48%
EPS (Basic)	1.31	6.34	-0.69	2.81	3.28	4.09	-1.65	4.21	4.32	-
Diluted Shares Outstanding	53.36M	53.53M	52.07M	51.14M	50.6M	50.84M	49.89M	50.18M	50.08M	48.09M
Basic Shares Outstanding	52.98M	53.1M	51.88M	50.72M	50.21M	50.26M	49.88M	49.76M	49.7M	47.88M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

PBH Balance Sheet

Prestige Consumer Healthcare Inc. (PBH) balance sheet — assets, liabilities & shareholders' equity

Line item	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Total Current Assets	334.43M	303.48M	300.94M	365.65M	269.83M	293.27M	391.74M	375.04M	448.33M	433.43M
Cash & Short-Term Investments	41.85M	32.55M	27.53M	94.76M	32.3M	27.18M	58.49M	46.47M	97.88M	62.37M
Cash Only	41.85M	32.55M	27.53M	94.76M	32.3M	27.18M	58.49M	46.47M	97.88M	62.37M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	136.74M	140.88M	148.79M	150.52M	114.67M	139.33M	167.02M	176.78M	194.29M	190.46M
Days Sales Outstanding	56.58	49.39	55.66	57.05	44.37	46.79	54.06	57.34	62.33	62.18
Inventory	115.61M	118.55M	119.88M	116.03M	114.96M	120.34M	162.12M	138.72M	147.71M	163.59M
Days Inventory Outstanding	110.53	93.12	104.13	103.09	105.99	94.23	117.78	101.08	107.12	118.14
Other Current Assets	40.23M	0	4.74M	0	0	0	4.12M	13.08M	8.44M	17M
Total Non-Current Assets	3.58B	3.46B	3.14B	3.15B	3.16B	3.38B	2.96B	2.94B	2.95B	3.06B
Property, Plant & Equipment	50.59M	52.55M	51.18M	90.72M	102.77M	98.53M	89.53M	89.33M	127.84M	174.74M
Fixed Asset Turnover	17.43x	19.81x	19.07x	10.62x	9.18x	11.03x	12.60x	12.60x	8.90x	8.04x
Goodwill	615.25M	620.1M	578.58M	575.18M	578.08M	578.98M	527.55M	527.73M	527.42M	581.25M
Intangible Assets	2.9B	2.78B	2.51B	2.48B	2.48B	2.7B	2.34B	2.32B	2.3B	2.3B
Long-Term Investments	-715.09M	-26K	-399.57M	0	0	0	0	0	0	0
Other Non-Current Assets	7.45M	3.57M	3.13M	2.96M	2.86M	3.27M	3M	5.72M	3.27M	13.53M
Total Assets	3.91B▲ 0%	3.76B▼ 3.9%	3.44B▼ 8.5%	3.51B▲ 2.1%	3.43B▼ 2.4%	3.67B▲ 7.0%	3.35B▼ 8.6%	3.32B▼ 1.1%	3.4B▲ 2.5%	3.49B▲ 0%
Asset Turnover	0.23x	0.28x	0.28x	0.27x	0.28x	0.30x	0.34x	0.34x	0.33x	0.32x
Asset Growth %	32.64%	-3.85%	-8.5%	2.12%	-2.41%	7.04%	-8.63%	-1.05%	2.53%	15.02%
Total Current Liabilities	162.01M	123.2M	126.98M	149.88M	122.14M	143.42M	160.72M	117.05M	106.62M	139.56M
Accounts Payable	70.22M	61.39M	56.56M	62.38M	45.98M	55.76M	62.74M	38.98M	18.93M	42.95M
Days Payables Outstanding	67.13	48.22	49.13	55.42	42.39	43.66	45.58	28.4	13.72	23.88
Short-Term Debt	0	0	0	0	0	0	0	0	0	8.63M
Deferred Revenue (Current)	492K	0	0	0	0	0	0	0	0	0
Other Current Liabilities	22.84M	1.9M	88K	13.39M	14.07M	19.59M	14.29M	57.13M	14.21M	87.51M
Current Ratio	2.06x	2.46x	2.37x	2.44x	2.21x	2.04x	2.44x	3.20x	4.20x	4.20x
Quick Ratio	1.35x	1.50x	1.43x	1.67x	1.27x	1.21x	1.43x	2.02x	2.82x	2.82x
Cash Conversion Cycle	99.98	94.28	110.66	104.72	107.97	97.36	126.25	130.01	155.73	156.44
Total Non-Current Liabilities	2.93B	2.46B	2.22B	2.19B	1.95B	1.95B	1.75B	1.55B	1.46B	1.53B
Long-Term Debt	2.19B	1.99B	1.8B	1.73B	1.48B	1.48B	1.35B	1.13B	992.36M	1.05B
Capital Lease Obligations	0	0	0	29.5M	26.52M	20.59M	11.54M	7.7M	43.36M	161.1M
Deferred Tax Liabilities	715.09M	442.52M	399.57M	407.81M	434.05M	444.92M	380.43M	403.6M	419.59M	1.74B
Other Non-Current Liabilities	17.97M	23.33M	20.05M	25.44M	8.61M	7.48M	8.16M	9.19M	5.39M	3.46M
Total Liabilities	3.09B	2.58B	2.35B	2.34B	2.07B	2.09B	1.91B	1.66B	1.57B	1.67B
Total Debt	2.19B	1.99B	1.8B	1.77B	1.51B	1.51B	1.37B	1.14B	1.04B	1.1B
Net Debt	2.15B	1.96B	1.77B	1.67B	1.48B	1.48B	1.31B	1.09B	946.37M	1.04B
Debt / Equity	2.67x	1.69x	1.64x	1.51x	1.12x	0.95x	0.94x	0.69x	0.57x	0.57x
Debt / EBITDA	9.48x	7.99x	18.12x	5.37x	4.62x	4.16x	133.90x	3.05x	2.85x	3.11x
Net Debt / EBITDA	9.30x	7.86x	17.84x	5.08x	4.53x	4.09x	128.17x	2.93x	2.58x	2.58x
Interest Coverage	2.20x	2.03x	0.64x	3.02x	3.61x	5.13x	-0.32x	5.10x	7.07x	7.40x
Total Equity	822.55M▲ 0%	1.18B▲ 43.3%	1.1B▼ 7.0%	1.17B▲ 6.9%	1.36B▲ 16.0%	1.58B▲ 16.1%	1.45B▼ 8.3%	1.66B▲ 14.4%	1.83B▲ 10.9%	1.83B▲ 0%
Equity Growth %	10.51%	43.29%	-7.02%	6.86%	16%	16.15%	-8.27%	14.37%	10.86%	28.94%
Book Value per Share	15.41	22.02	21.05	22.90	26.84	31.03	29.01	32.98	36.64	38.04
Total Shareholders' Equity	822.55M	1.18B	1.1B	1.17B	1.36B	1.58B	1.45B	1.66B	1.83B	1.83B
Common Stock	533K	534K	536K	538K	540K	544K	548K	555K	560K	562K
Retained Earnings	396.71M	736.28M	701.82M	844.1M	1.01B	1.21B	1.13B	1.34B	1.56B	1.69B
Treasury Stock	-6.59M	-7.67M	-59.93M	-117.62M	-130.73M	-133.65M	-189.11M	-219.62M	-277.21M	-438.55M
Accumulated OCI	-26.35M	-19.32M	-25.75M	-44.16M	-19.8M	-19.03M	-31.56M	-34.49M	-37.66M	-30.23M
Minority Interest	0	0	0	0	0	0	0	0	0	0

PBH Cash Flow Statement

Prestige Consumer Healthcare Inc. (PBH) cash flow — operating, investing & free cash flow history

Line item	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Cash from Operations	147.77M	210.11M	189.28M	217.12M	235.61M	259.92M	229.72M	248.93M	251.51M	251.51M
Operating CF Margin %	16.75%	20.18%	19.4%	22.55%	24.98%	23.92%	20.37%	22.12%	22.11%	-
Operating CF Growth %	-15.24%	42.19%	-9.91%	14.71%	8.51%	10.32%	-11.62%	8.36%	1.04%	39.32%
Net Income	69.39M	339.57M	-35.8M	142.28M	164.68M	205.38M	-82.31M	209.34M	214.6M	186.5M
Depreciation & Amortization	25.79M	33.43M	31.78M	29M	30.16M	32.09M	32.63M	30.68M	30.17M	30.17M
Stock-Based Compensation	8.15M	8.91M	7.44M	7.64M	8.54M	9.04M	12.4M	14.01M	11.16M	10.92M
Deferred Taxes	-5.78M	-269.09M	-40.55M	13.85M	18.63M	9.98M	-60.77M	23.07M	0	7.13M
Other Non-Cash Items	63.55M	113.05M	234.74M	15.55M	19.19M	14.38M	381.61M	11.66M	37.52M	60.83M
Working Capital Changes	-13.34M	-15.76M	-8.32M	8.8M	-5.6M	-10.95M	-53.85M	-39.83M	-41.94M	-18.92M
Change in Receivables	-18.94M	-5.04M	-2.98M	-2.85M	36.87M	-24.65M	-24.93M	-6.32M	-16.33M	-27.29M
Change in Inventory	-10.26M	-2.48M	-10.54M	2.93M	2.97M	663K	-42.23M	24.44M	-9.31M	-3M
Change in Payables	21.45M	-10.03M	-3.99M	6.21M	-17.34M	9.15M	7.26M	-24.97M	-19.41M	17.9M
Cash from Investing	-694.6M	-11.56M	55.43M	-16.57M	-22.24M	-256.51M	-11.58M	-20.11M	-17.45M	-136.91M
Capital Expenditures	-2.98M	-12.53M	-10.48M	-14.56M	-22.24M	-9.64M	-7.78M	-9.55M	-8.22M	-9.45M
CapEx % of Revenue	0.34%	1.2%	1.07%	1.51%	2.36%	0.89%	0.69%	0.85%	0.72%	-
Acquisitions	-693.12M	0	65.91M	-2.76M	0	-246.87M	-3.8M	-10.56M	-9.23M	-125.53M
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	1.5M	970K	65.91M	750K	0	0	0	0	0	-1.93M
Cash from Financing	561.86M	-208.96M	-249.33M	-131.43M	-279.42M	-7.57M	-185.85M	-241.01M	-182.07M	-129.45M
Debt Issued (Net)	569.5M	-209M	-200M	-68.48M	-251.44M	-5.58M	-137.75M	-227.83M	-139.54M	35.59M
Equity Issued (Net)	-1000K	0	-1000K	-1000K	-1000K	0	-1000K	-1000K	-1000K	-4M
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-1.43M	-1.07M	-49.98M	-56.72M	-11.87M	0	-50M	-25M	-51.51M	-166.91M
Other Financing	-6.21M	45K	-2.28M	-6.23M	-16.11M	-1.99M	1.91M	11.81M	-5.83M	1.11M
Net Change in Cash	14.63M▲ 0%	-9.31M▼ 163.6%	-5.02M▲ 46.1%	67.23M▲ 1439.8%	-62.46M▼ 192.9%	-5.12M▲ 91.8%	31.3M▲ 711.8%	-12.02M▼ 138.4%	51.41M▲ 527.7%	11.5M▲ 0%
Free Cash Flow	144.79M▲ 0%	197.58M▲ 36.5%	178.8M▼ 9.5%	202.56M▲ 13.3%	213.36M▲ 5.3%	250.28M▲ 17.3%	221.93M▼ 11.3%	239.38M▲ 7.9%	243.29M▲ 1.6%	267.19M▲ 0%
FCF Margin %	16.42%	18.98%	18.32%	21.03%	22.62%	23.03%	19.68%	21.27%	21.38%	24.21%
FCF Growth %	-15.22%	36.45%	-9.5%	13.29%	5.33%	17.3%	-11.33%	7.86%	1.64%	7.44%
FCF per Share	2.71	3.69	3.43	3.96	4.22	4.92	4.45	4.77	4.86	4.86
FCF Conversion (FCF/Net Income)	2.13x	0.62x	-5.29x	1.53x	1.43x	1.27x	-2.79x	1.19x	1.17x	1.43x
Interest Paid	85.21M	98.57M	98.23M	92.17M	80.29M	61.36M	54.24M	63.25M	47.8M	32.26M
Taxes Paid	48M	24.44M	32.8M	30.6M	34.38M	46.57M	40.74M	59.64M	52.12M	43.69M

PBH Key Ratios

Prestige Consumer Healthcare Inc. (PBH) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	8.86%	33.94%	-3.15%	12.55%	13.02%	13.99%	-5.44%	13.5%	12.3%	10.19%
Return on Invested Capital (ROIC)	5.8%	5.3%	1.69%	7.65%	7.85%	8.39%	-0.58%	9.33%	9.14%	9.14%
Gross Margin	56.72%	55.37%	56.94%	57.34%	58.03%	57.11%	55.45%	55.49%	55.76%	56.38%
Net Margin	7.87%	32.61%	-3.67%	14.77%	17.46%	18.9%	-7.3%	18.6%	18.86%	16.9%
Debt / Equity	2.67x	1.69x	1.64x	1.51x	1.12x	0.95x	0.94x	0.69x	0.57x	0.57x
Interest Coverage	2.20x	2.03x	0.64x	3.02x	3.61x	5.13x	-0.32x	5.10x	7.07x	7.40x
FCF Conversion	2.13x	0.62x	-5.29x	1.53x	1.43x	1.27x	-2.79x	1.19x	1.17x	1.43x
Revenue Growth	9.4%	18.04%	-6.28%	-1.31%	-2.04%	15.21%	3.76%	-0.21%	1.1%	-1.27%

PBH SEC Filings & Documents

Prestige Consumer Healthcare Inc. (PBH) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Mar 20, 2026·SEC

Material company update

Feb 5, 2026·SEC

Material company update

Nov 6, 2025·SEC

10-K Annual Reports

FY 2025

May 9, 2025·SEC

FY 2024

May 15, 2024·SEC

FY 2023

May 5, 2023·SEC

10-Q Quarterly Reports

FY 2026

Feb 5, 2026·SEC

FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 7, 2025·SEC

PBH Frequently Asked Questions

Prestige Consumer Healthcare Inc. (PBH) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Prestige Consumer Healthcare Inc. (PBH) reported $1.10B in revenue for fiscal year 2025. This represents a 12654% increase from $8.7M in 2001.

Prestige Consumer Healthcare Inc. (PBH) grew revenue by 1.1% over the past year. Growth has been modest.

Yes, Prestige Consumer Healthcare Inc. (PBH) is profitable, generating $186.5M in net income for fiscal year 2025 (18.9% net margin).

Dividend & Returns

Prestige Consumer Healthcare Inc. (PBH) has a return on equity (ROE) of 12.3%. This is reasonable for most industries.

Prestige Consumer Healthcare Inc. (PBH) generated $267.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More PBH

Prestige Consumer Healthcare Inc. (PBH) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Prestige Consumer Healthcare Inc.(PBH)Earnings, Financials & Key Ratios

PBH Key Insights

✓Strengths

✗Weaknesses

PBH Price & Volume

PBH Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

PBH Recent Earnings

PBH Peer Comparison

Compare PBH vs Peers

vs SPB

vs AMZN

Compare Top 5

PBH Income Statement

PBH Balance Sheet

PBH Cash Flow Statement

PBH Key Ratios

PBH SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

PBH Frequently Asked Questions

Explore More PBH

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation